After studying this chapter, you should be able to:
Some patients come to medical attention because of an increase in red cell mass, manifested by hematocrit and hemoglobin levels that exceed the upper limit of normal for age and sex. The terms erythrocytosis and polycythemia are often used interchangeably. The former is preferred because it covers all conditions in which the red cell mass is increased. Polycythemia is a more restrictive term, implying not only increased hemoglobin and hematocrit levels but also leukocytosis and thrombocytosis.
In the initial evaluation of the patient, it is important to consider whether the hematocrit and hemoglobin levels might be falsely elevated because of a reduction in plasma volume. False or “pseudo” erythrocytosis may be due to dehydration such as from heat-induced diaphoresis or loss of gastrointestinal fluid from vomiting or diarrhea. In addition to these acute conditions, modest elevations of hemoglobin (Hb) and hematocrit (Hct) levels may be caused by chronic contraction in plasma volume, most often encountered in hypertensive, overweight, middle-aged males, a condition known as stress erythrocytosis or Gaisböck syndrome. However, when levels exceed two standard deviations above normal (Hb >17.5 g/dL, Hct >54% in males; Hb >16.0 g/dL, Hct >46% in females), it is likely that the patient has true erythrocytosis.
Many individuals with erythrocytosis are asymptomatic. However, as the red cell mass increases, they develop a ruddy or florid facial complexion. With further increases, the patient may develop central nervous system symptoms, such as forgetfulness, lethargy, or headache, and may have signs of excess cardiac preload, such as distended neck veins and hepatic congestion. More often, the clinical presentation is dominated by symptoms and signs related to the underlying cause rather than the erythrocytosis per se.
Establishing the cause of erythrocytosis can be a diagnostic challenge that requires the application of sound pathophysiologic principles. Table 12-1 presents an etiologic framework based on different mechanisms responsible for the expansion of the red cell mass. In primary erythrocytosis, the increase is due to the presence of abnormal erythroid progenitors in the marrow that proliferate in an erythropoietin (Epo)-independent fashion. In these patients, the abundant oxygen supply from the elevated hemoglobin concentration dampens expression of the Epo gene in the kidney, and as a result, plasma Epo levels are low. In contrast, secondary erythrocytosis is caused by elevated plasma Epo levels, which drive increased marrow red cell production. Elevated Epo levels are seen in individuals with hypoxia of any cause and, more rarely, in patients with Epo-releasing tumors or with inherited defects in oxygen sensing in the kidney.
TABLE 12-1Causes of Erythrocytosis ||Download (.pdf) TABLE 12-1 Causes of Erythrocytosis
Primary (autonomous) erythrocytosis → Low plasma Epo